Open Scanner

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Certara Inc

CERT
Current price
14.64 USD +0.23 USD (+1.60%)
Last closed 14.41 USD
Sector Healthcare
Industry Health Information Services
Exchange NASDAQ
Capitalization 2 340 130 816 USD
Yield for 12 month -17.38 %
Week
Month
Year
CERT
21.11.2021 - 28.11.2021

Certara, Inc., together with its subsidiaries, provides software products and technology-enabled services to customers for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access. It offers medicines to patients using biosimulation software, technology, and services to transform drug discovery and development. The company also provides related technology-enabled services to guide its customers' new drugs through the regulatory submission process and into the market. Its technology-enabled services include mechanistic biosimulation, empirical biosimulation, drug development and regulatory strategy, clinical pharmacology, model-based meta-analysis, regulatory writing and medical communications, regulatory operations, and market access. Further, company offers software, comprising mechanistic biosimulation platform, empirical PK/PD biosimulation platform, data standardization and compliance software, scientific informatics platform, clinical outcomes databases for biosimulation, authoring and management of regulatory submissions platform, and market access communication platform. The company serves biopharmaceutical companies, and academic and government institutions. It has operations in the United States, Australia, Canada, China, France, Germany, India, Italy, Japan, Luxembourg, the Netherlands, the Philippines, Poland, Portugal, Spain, Switzerland, and the United Kingdom. Certara Inc. was founded in 2008 and is headquartered in Princeton, New Jersey. Address: 100 Overlook Center, Princeton, NJ, United States, 08540

Analytics

WallStreet Target Price

17.14 USD

P/E ratio

Dividend Yield

Current Year

+335 644 000 USD

Last Year

+286 104 000 USD

Current Quarter

+85 576 000 USD

Last Quarter

+90 450 000 USD

Current Year

+203 067 000 USD

Last Year

+174 488 000 USD

Current Quarter

+49 700 000 USD

Last Quarter

+54 226 000 USD

Key Figures CERT

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA 82 670 000 USD
Operating Margin TTM -6.78 %
PE Ratio
Return On Assets TTM 1.17 %
PEG Ratio
Return On Equity TTM -3.2 %
Wall Street Target Price 17.14 USD
Revenue TTM 352 960 000 USD
Book Value 6.58 USD
Revenue Per Share TTM 2.23 USD
Dividend Share
Quarterly Revenue Growth YOY 1 %
Dividend Yield
Gross Profit TTM 203 067 000 USD
Earnings Share -0.22 USD
Diluted Eps TTM -0.22 USD
Most Recent Quarter III 2023
Quarterly Earnings Growth YOY -14.1 %
Profit Margin -9.56 %

Dividend Analytics CERT

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History CERT

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor
Payout Ratio
Last Split Date
Dividend Date

Stock Valuation CERT

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE 30.8642
Enterprise Value Revenue 6.718
Price Sales TTM 6.63
Enterprise Value EBITDA 62.6682
Price Book MRQ 2.225

Financials CERT

1 year
3 years
5 years
10 years
Results 2019 Dynamics

Technical indicators CERT

For 52 weeks

11.81 USD 24.96 USD
50 Day MA 13.79 USD
Shares Short Prior Month 5 273 968
200 Day MA 18.16 USD
Short Ratio 6.05
Shares Short 4 689 121
Short Percent 3.93 %